Skip to main content

Table 1 Clinicopathological features of the study cohort

From: Practicability of clinical application of bladder cancer molecular classification and additional value of epithelial-to-mesenchymal transition: prognostic value of vimentin expression

Clinicopathological features of the immunohistochemistry cohort

Primary bladder cancer

 Individuals, n

126

 Gender, n (%)

  Male

101 (80.2)

  Female

25 (19.8)

 Median age, years (range)

71 (61–77)

 Grade, n (%)

  Papillary, low-grade

28/126 (22.2)

  Papillary, high-grade

20/126 (15.9)

  Invasive, high-grade

78/126 (61.9)

 Pathological Stage, n (%)a

  pTa/pT1 (NMIBC)

51/123 (41.5)

  pT2-4 (MIBC)

72/123 (58.5)

  1. NMIBC non-muscle invasive bladder cancer, MIBC muscle invasive bladder cancer
  2. aFor 3 patients stage could not be ascertained as clinical data was missing/not available to the investigators